Moreover, we further validated the existence of a correlation between ETV4 and Fibrinogen-like protein 1 (FGL1), a major ligand for the inhibitory receptor LAG3, in pancreatic cancer, suggesting that the ETV4-FGL1 axis may be a key player in tumor immune evasion (19). This evidence concerns the gene FGL1 and pancreatic neoplasm.